| Patents for A61K 49 - Preparations for testing in vivo (35,376) |
|---|
| 05/15/2001 | US6232107 Nucleotide sequence coding green fluorescent protein; for use in diagnosis of microorganism infection |
| 05/15/2001 | US6232080 Monoclonal antibodies immunoreactive with lipopolysaccharide binding protein (LBP) and methods of their use |
| 05/15/2001 | US6231834 Methods for ultrasound imaging involving the use of a contrast agent and multiple images and processing of same |
| 05/15/2001 | US6231613 Methods for soft tissue augmentation in mammals |
| 05/15/2001 | CA2291456A1 Diagnostic agents for pancreatic exocrine function |
| 05/15/2001 | CA2158054C Conjugates of proteins and bifunctional ligands |
| 05/15/2001 | CA2041638C Recombinant polynucleotide constructs suitable for providing secretion of pai-2 |
| 05/10/2001 | WO2001032861A1 Tumour suppressor genes from chromosome 16 |
| 05/10/2001 | WO2001032630A1 Oligobenzimidazole derivatives and their use as dna transfection agents |
| 05/10/2001 | WO2001032210A2 Compositions for treating atheroma and neoplastic tissue |
| 05/10/2001 | WO2001032209A1 A novel method of diagnosing, monitoring, staging, imaging and treating cancer |
| 05/10/2001 | WO2001032184A2 Abc1 modulation for the modulation of cholesterol transport |
| 05/10/2001 | WO2001032139A2 Method for the formulation of substances having a low water-solubility and lipophilicity and formulation thus obtained |
| 05/10/2001 | WO2001032070A2 Reagents and methods for diagnosing, imaging and treating atherosclerotic disease |
| 05/10/2001 | WO2000057923A3 Radioactive seed with multiple markers and method for using same |
| 05/10/2001 | US20010001059 Locating single milk duct, introducing washing fluid throughout duct without rupture, collecting at least a portion of the washing fluid from the duct and identifying materials in the washing fluid; breast cancer detection |
| 05/10/2001 | US20010001038 A free-flowing suspension of activated carbon particles ground and graded to <50 mu; antiagglomerants; grinding in a cylindrical rod mill in a chamber coated with a nonabrasive lining; accuracy |
| 05/10/2001 | US20010001011 System and method for radiographic imaging of tissue |
| 05/10/2001 | CA2389964A1 A novel method of diagnosing, monitoring, staging, imaging and treating cancer |
| 05/10/2001 | CA2389849A1 Reagents and methods for diagnosing, imaging and treating atherosclerotic disease |
| 05/10/2001 | CA2389778A1 Oligobenzimidazole derivatives and their use as dna transfection agents |
| 05/10/2001 | CA2389237A1 Abc1 modulation for the modulation of cholesterol transport |
| 05/10/2001 | CA2389147A1 Method for the formulation of substances having a low water-solubility and lipophilicity and formulation thus obtained |
| 05/09/2001 | EP1097992A2 Modified bioluminescent proteins and their use |
| 05/09/2001 | EP1097991A2 Human adenylate cyclase IX and use therefor |
| 05/09/2001 | EP1097942A2 Murine monoclonal antibody (5c8) recognizes a human glycoprotein on the surface of T-lymphocytes |
| 05/09/2001 | EP1097201A1 Snurpotine i human m 3?g-cap specific nucleus import receptor protein with new domain structure, the production and use thereof |
| 05/09/2001 | EP1096956A1 Intracellular sensitizers for sonodynamic therapy |
| 05/09/2001 | EP1096955A2 Cancer treatment methods using antibodies to aminophospholipids |
| 05/09/2001 | EP1096941A1 Bone marrow cells as a source of neurons for brain and spinal cord repair |
| 05/09/2001 | EP0680341B1 Phase shift colloids as ultrasound contrast agents |
| 05/08/2001 | US6230041 Method for imaging an artery using a magnetic resonance contrast agent |
| 05/08/2001 | US6229002 Complex of nucleic acid which binds to platelet derived growth factor and nonimmunogenic, high molecular weight compound; for targeted diagnostic and therapy; anticarcinogenic agents; cardiovascular disorders; kidney disease |
| 05/08/2001 | US6228605 Detection of helicobacter pylori in the stomach |
| 05/08/2001 | US6228399 Cyclosporin, a phospholipid and at least one surface modifier, |
| 05/08/2001 | US6228344 Method of measuring physiological function |
| 05/04/2001 | CA2288530A1 Immunofluorescence compound for imaging of tumors |
| 05/03/2001 | WO2001031334A1 Method and means for detecting inflammatory processes |
| 05/03/2001 | WO2001030967A2 Fluorescent cobalamins and uses thereof |
| 05/03/2001 | WO2001030816A1 NON-ANAPHYLACTIC FORMS OF GRASS POLLEN Ph1 p 6 ALLERGEN AND THEIR USE |
| 05/03/2001 | WO2001030754A2 Micro-cluster liquids and methods of making and using them |
| 05/03/2001 | WO2001030398A2 Ligand chelated paramagnetic mri contrast agents |
| 05/03/2001 | WO2001030397A2 Ultrasound inducement of artial and ventricular rhythms |
| 05/03/2001 | WO2001030396A2 Improved suspensions of ultrasound contrast media |
| 05/03/2001 | WO2001013893A3 Use of simple amino acids to form porous particles |
| 05/03/2001 | WO2001005968A9 Angiocidin: a cys-ser-val-thr-cys-gly specific tumor cell adhesion receptor |
| 05/03/2001 | WO2000068263A3 Stereoselective antifibrillogenic peptides and peptidomimetics thereof |
| 05/03/2001 | US20010000727 Pulmonary and cardiac vasculature MRI images are obtained by delivering xenon-129 gas to a patient via inhalation, exciting the dissolved phase gas with a large flip angle pulse and generating a corresponding image |
| 05/03/2001 | US20010000726 Detecting a spatial distribution of at least one noble gas by nuclear magnetic resonance spectrometry and generating a representation of spatial distribution of the noble gas preferably xenone-129 and/or helium -3 |
| 05/03/2001 | CA2388934A1 Micro-cluster liquids and methods of making and using them |
| 05/03/2001 | CA2388100A1 Method and means for detecting inflammatory processes |
| 05/03/2001 | CA2387260A1 Non-anaphylactic forms of grass pollen ph1 p 6 allergen and their use |
| 05/02/2001 | EP1095274A1 Trifunctional reagent for conjugation to a biomolecule |
| 05/02/2001 | EP1095136A1 Cells and animals deficient in protein kinase c epsilon |
| 05/02/2001 | EP1095064A1 Amides of hyaluronic acid and the derivatives thereof and a process for their preparation |
| 05/02/2001 | EP1095011A1 Novel fluorescent lanthanide chelates |
| 05/02/2001 | EP1094843A1 Targeted site specific drug delivery compositions and method of use |
| 05/02/2001 | EP1094840A1 Use of texaphyrins in macrophage-mediated disease |
| 05/02/2001 | EP1094799A1 Apomorphine-containing dosage forms for ameliorating male erectile dysfunction |
| 05/02/2001 | EP0966427B1 Preparation of acid amides and metallisation of compounds |
| 05/02/2001 | EP0882010B1 Pharmaceutical agents containing perfluoroalkyl-containing metal complexes and the use thereof in tumour therapy and interventional radiology |
| 05/02/2001 | CN1293067A Use of 4-(4-ethoxybenzyl)-3,6,9-tri(carboxymethyl)-3,6,9-triazohendecanedioic acid calcium composition |
| 05/02/2001 | CN1293036A Use of 4-(4-ethoxygenzyl)-3,6,9-tri(carboxymethyl)-3,6,9-triazohendecanedioic acid calcium composition |
| 05/01/2001 | US6226352 System and method for radiographic imaging of tissue |
| 05/01/2001 | US6225303 Use of green porphyrins to treat neovasculature in the eye |
| 05/01/2001 | US6225120 Detection of modulator of receptor protein activity; providing nematode, isolated nematode cell or mammalian cell expressing receptor activity, incubate with modulator and detect amplification in receptor activity |
| 05/01/2001 | US6225047 Use of retentate chromatography to generate difference maps |
| 05/01/2001 | US6224644 Cyanine dyes and synthesis methods thereof |
| 04/26/2001 | WO2001028982A1 Diethylenetriaminepenta acetic acid derivatives |
| 04/26/2001 | WO2001028594A2 Tumor detection by imaging and therapy of tumors |
| 04/26/2001 | WO2001028587A2 Magnetic targeted carrier |
| 04/26/2001 | WO2000045854A3 Preparations for time-limited marking of biopsy sites |
| 04/26/2001 | WO2000037114B1 Methods and compositions comprising monitoring devices |
| 04/26/2001 | DE19950933A1 Use of St. John's wort constituents for photodynamic diagnosis and/or therapy of mouth and malignant brain disorders |
| 04/26/2001 | CA2387925A1 Magnetic targeted carrier composed of iron and porous materials for the targeted delivery of biologically active agents |
| 04/25/2001 | CN1292688A Methods and compositions for detection and diagnosis of infectious diseases |
| 04/25/2001 | CN1064851C Microparticle, manufacture of same and application in diagnosis |
| 04/24/2001 | US6221622 Diagnosing mammary gland tumors; recovering fluid from mammary glands and evaluating the morphology of cells in the recovered fluid |
| 04/24/2001 | US6221387 Gelified microspheres, their method of preparation and their applications |
| 04/24/2001 | US6221337 Microbubbles surrounded by a monolayer of negatively charged phospholipids as contrast agents |
| 04/24/2001 | US6221334 Polyaza macrocyclic ligands chelated to superparamagnetic or paramagnetic metals and coupled to folate-receptor binding ligands through the gamma carboxylate of folate |
| 04/19/2001 | WO2001026661A1 Compositions comprising oxophosphonate-based metalloproteinase inhibitors |
| 04/19/2001 | WO2001026635A2 Bioadhesive nanoparticulate compositions having cationic surface stabilizers |
| 04/19/2001 | WO2000061132A8 Compositions containing immunotoxins and agents that inhibit dendritic cell maturation for inducing immune tolerance to a graft |
| 04/19/2001 | DE19950311A1 Stable storage of parenteral ultrasonic contrast agent formulation, using vial closed with dry stopper to prevent reduction of in vivo effectiveness |
| 04/19/2001 | DE19947559A1 Antikörper-Farbstoffkonjugate gegen Zielstrukturen der Angiogenese zur intraoperativen Tumorranddarstellung Antibody-dye conjugates against targets angiogenesis for intraoperative tumor boundary representation |
| 04/19/2001 | CA2386848A1 Compositions comprising oxophosphonate-based metalloproteinase inhibitors |
| 04/18/2001 | EP1091724A1 Vascular embolizing compositions comprising ethyl lactate and methods for their use |
| 04/18/2001 | EP0576519B1 Improvements in or relating to contrast agents |
| 04/17/2001 | US6218595 Genetically engineered cells; for use as test models in the treatment of parkinson's disease or dyskinesis |
| 04/17/2001 | US6218594 Guinea pig model for leiomyomas |
| 04/17/2001 | US6218358 For assaying for functional odor receptors in intact nasal epithelium of mammals such as rats and mice |
| 04/17/2001 | US6218136 Methods of the identification of pharmaceutically active compounds |
| 04/17/2001 | US6217886 Materials and methods for making improved micelle compositions |
| 04/17/2001 | US6217850 Method of making lyophilized microbubble compositions useful as contrast agents |
| 04/17/2001 | US6217849 Iodinated x-ray opacity compound |
| 04/17/2001 | US6217848 Dye-peptide complex |
| 04/17/2001 | US6217844 Methods for detecting lesions in dense breast tissue using LHRH antagonists |
| 04/17/2001 | CA2163107C Improved detection and therapy of lesions with biotin/avidin-metal chelating protein conjugates |
| 04/17/2001 | CA2020142C Derivatized dtpa complexes |